Viral Disease Diagnosis Market Size & Share Report, Growth, Trends, 2032

Viral Disease Diagnosis Market Insights

According to Zion Market Research, the global Viral Disease Diagnosis Market was worth USD 20.87 Billion in 2023. The market is forecast to reach USD 42.84 Billion by 2032, growing at a compound annual growth rate (CAGR) of 8.32% during the forecast period 2024-2032. The report offers a comprehensive analysis of the market, highlighting the factors that will determine growth, potential challenges, and opportunities that could emerge in the Viral Disease Diagnosis industry over the next decade.

Request Free Sample

Viruses are tiny organisms that cause infection within the bodies of living organisms. They are made up of genetic materials. Viruses attack and attach themselves to the host cell, thus stopping the original functionality of that cell. Owing to this an infection occurs in the body of the organism. There are quite a lot of ways by which viruses can be transmitted within the body such as unsafe sex and contact with the infected person. The risk also increases due to poor personal hygiene. The diagnosis of viral diseases is very important in order to decrease the danger of epidemics and to provide timely treatment. The spread of the viral diseases is a public concern across communities around the world.

Global Viral Disease Diagnosis Market: Segmentation

The viral disease diagnosis market is globally segmented into end users, diagnostic tests, virus types, and geography. All the segments have been analyzed based on present and future trends and the market is estimated from 2024 to 2032.

On the basis of end users, the global market is segregated into hospitals, physician clinics, nursing homes, and commercial laboratories.

Based on the diagnostic test, the market is categorized into serodiagnostic tests, specimen examination, and viral isolation.

Depending on the virus type, the market is divided into Dengue virus, Hepatitis virus, HIV-1, Human Metapneumovirus, Measles Virus, Rabies virus, Avian Influenza, Enterovirus, Coronavirus, Poliovirus, and others.

Geographically, the viral disease diagnosis market is diversified into Asia-Pacific, Europe, North America, and the Rest of the World.

Request Free Sample

Global Viral Disease Diagnosis Market: Growth Factors

The increasing occurrences of infections that are viral, the technological advancements in molecular diagnostics, and clinical research are some of the key factors that are driving the viral disease diagnosis market globally. Furthermore, the development of precise rapid screening tests along with the improved detection time and the preference for treatments that are effective are further boosting the growth of the market. However, the continuous variations in the viral genome and the diverse environmental conditions lead to numerous strains of viruses that challenge the consumption of existing viral disease diagnostic tests. Low awareness about diagnostic tests, lack of expertise, and the limited availability of virological laboratories particularly in emerging countries result in viral disease diagnostic tests that are not utilized completely by clinicians.

Viral Disease Diagnosis Market: Report Scope

Global Viral Disease Diagnosis Market: Regional Analysis

The regions such as North America, followed by Europe, have the major market for viral molecular diagnostics owing to the factors such as ease of access, economic affordability of diagnostic tests for viral diseases, and the developed healthcare infrastructure in this region. The Asia Pacific expects to show a high rate of growth in the viral molecular diagnostics market in the coming years owing to soaring cases of viral infectious diseases and increase awareness about disease diagnosis and treatments in the region. Mounting demographics and economies in emergent countries such as India and China anticipate leading the expansion in the viral molecular diagnostics market.

Global Viral Disease Diagnosis Market: Competitive Players

Some of the key market players that are involved in the viral disease diagnosis market include Cepheid, Thermo Fischer Scientific, Becton Dickinson and Company, Novartis Diagnostics, Abbott Laboratories, Roche Diagnostics, bioMerieux, Affymetrix, and Siemens AG.

The report segments the Global Viral Disease Diagnosis market as follows:

Global Viral Disease Diagnosis Market: End-users Segment Analysis

• Hospitals
• Physician clinics
• Nursing homes
• Commercial laboratories

Global Viral Disease Diagnosis Market: Diagnostic test Segment Analysis

• Serodiagnostic tests
• Specimen examination
• Viral isolation

Global Viral Disease Diagnosis Market: Virus Type Segment Analysis

• Dengue virus
• Hepatitis virus
• HIV-1
• Human Metapneumovirus
• Measles Virus
• Rabies virus
• Avian Influenza
• Enterovirus
• Coronavirus
• Poliovirus
• Others

Global Viral Disease Diagnosis Market: Regional Segment Analysis

• North America

  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of The Middle East & Africa